Integrin signalling during tumour progression

Nature Reviews Molecular Cell Biology

Volumn 5, Issue 10, 2004, Pages 816-826

  Guo, Wenjun ^a   Giancotti, Filippo G ^a  

^a Weill Cornell Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN PROTEIN LIGASE; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3;

ANGIOGENESIS; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; GENE AMPLIFICATION; METASTASIS; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

CELL MOVEMENT; CELL SURVIVAL; EXTRACELLULAR MATRIX; INTEGRINS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 5044238876     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1490     Document Type: Review

References (131)

1. Giancotti, F. G. & Ruoslahti, E. Integrin signaling. Science 285, 1028-1032 (1999).
2. Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687 (2002).
3. Giancotti. F. G. & Tarone. G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu. Rev. Cell Dev. Biol. 19, 173-206 (2003).
4. Miranti, C. K. & Brugge, J. S. Sensing the environment: a historical perspective on integrin signal transduction. Nature Cell Biol. 4, E83-E90 (2002).
5. Schwartz, M. A. & Ginsberg, M. H. Networks and crosstalk: integrin signalling spreads. Nature Cell Biol. 4, E65-E68 (2002).
6. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
7. Bissell, M. J. & Radisky, D. Putting tumours in context. Nature Rev. Cancer 1, 46-54 (2001).
8. Wiseman, B. S. & Werb, Z. Stromal effects on mammary gland development and breast cancer. Science 298, 1046-1049 (2002).
9. Hynes, R. O. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants - or both? Cell 113, 821-823 (2003).
10. Liotta, L A., Steeg. P. S. & Stetler-Stevenson, W. G. Cancer metastasis and angtogenesis: an imbalance of positive and negative regulation. Cell 64, 327-336 (1991).
11. McDonald, D. M. & Baluk, P. Significance of blood vessel leakiness in cancer. Cancer Res. 62, 5381-5385 (2002).
12. Alitalo, K. & Carmeliet, P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1, 219-227 (2002).
13. Felding-Habermann, B. et al. Integrin activation controls metastasis in human breast cancer. Proc. Natl. Acad. Sci. USA 98, 1853-1858 (2001). Shows that integrin activation facilitates the adhesion of tumour cells to platelets in the circulation and, therefore, metastasis.
14. Borsig, L., Wong, R., Hynes, R. O., Vorki, N. M. & Varki, A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-much ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl Acad. Sci. USA 99, 2193-2198 (2002).
15. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the anglogenic switch during tumorigenesis. Cell 88, 353-364 (1996).
16. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
17. Eliceiri, B. P. & Cheresh, D. A. Adhesion events in angiogenesis. Curr. Opin. Cell Biol. 13, 563-568 (2001).
18. Hynes, R. O. A reevaluation of integrins as regulators of angiogenesis. Nature Med. 8, 918-921 (2002).
19. 4 integrin. Semin. Cancer Biol. 11, 129-141 (2001).
20. 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J. Cell Sci. 108, 2241-2251 (1995).
21. 3 integrin: adhesion mechanism for transformed glial cells. J. Clin. Invest. 86, 1924-1932 (1991).
22. Albelda, S. M. et al. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res. 50, 6757-6764 (1990).
23. 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl Acad. Sci. USA 92, 7411-7415 (1995).
24. Plantefaber, L. C. & Hynes, R. O. Changes in integrin receptors on oncogenically transformed cells. Cell 56, 281-290 (1989).
25. Vleminckx, K., Vakaet, L. Jr., Mareel, M., Fiers, W. & van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66, 107-119 (1991).
26. Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H. & Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193 (1998). Provides genetic evidence that loss of E-cadherin promotes malignant conversion of carcinoma.
27. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442-454 (2002).
28. Nieto, M. A. The snail superfamily of zinc-finger transcription factors. Nature Rev. Mol. Cell Biol. 3, 155-166 (2002).
29. 1- integrin signalling contributes to the disruption of epithelial polarity in breast carcinoma cells.
30. 1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. J. Cell Biol. 147, 1325-1340 (1999).
31. Sander, E. E. et al. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143, 1385-1398 (1998).
32. Fujita, Y. et al. Hakai, a c-Cbl-like protein, ubiqurtinates and induces endocytosis of the E-cadherin complex. Nature Cell Biol. 4, 222-231 (2002).
33. Avizienyte. E. et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signaling. Nature Cell Biol. 4, 632-638 (2002). Identifies a role for FAK in the disruption of adherers junctions in colon cancer.
34. Novak. A. et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc. Natl Acad. Sci. USA 95, 4374-4379 (1998).
35. -/- human colon carcinoma cells. Oncogene 20, 133-140 (2001).
36. 1 regulate matrix adhesion and cell-cell contact. J. Cell Biol. 163, 177-188 (2003).
37. Siegel, P. M. & Massague, J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nature Rev. Cancer 3, 807-821 (2003).
38. Derynck, R., Akhurst, R. J. & Balmain, A. TGF-β signaling in tumor suppression and cancer progression. Nature Genet. 29, 117-129 (2001).
39. 6 binds and activates latent TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 98, 319-328 (1999).
40. 8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J. Cell Biol. 157, 493-507 (2002).
41. Inaguma, Y. et al. Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev. Biol. 128, 245-255 (1988).
42. 6 cytoplasmic domain. J. Cell Biol. 127, 547-556 (1994).
43. Webb, D. J. Parsons, J. T. & Horwitz, A. F. Adhesion assembly, disassembly and turnover in migrating cell - over and over and over again. Nature Cell Boil. 4, E97-E100 (2002).
44. Ilic, D. et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544 (1995). Shows that FAK has a key role in cell migration.
45. Gabarra-Niecko, V., Schaller, M. D. & Dunty, J. M. FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev. 22, 359-374 (2003).
46. Sieg, D. J. et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nature Cell Biol. 2, 249-256 (2000).
47. Gary, L. A., Han, D. C., Pote, T.R., Hanks, S. K. & Guan, J. L. Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol. 140, 211-221 (1998).
48. Klemke, R. L. et al. CAS/Crk coupling serves as a 'molecular switch' for induction of cell migration. J. Cell Biol. 140, 961-972(1998). References 47 and 48 show that CAS and Crk function downstream of FAK in pro-migratory signalling.
49. Chen, R. et al. Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nature Cell Biol. 3, 439-444 (2001).
50. Webb, D. J. et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nature Cell Biol. 6, 154-161 (2004).
51. Gu, J. et al. She and FAK differentially regulate cell motility and directionality modulated by PTEN. J. Cell Biol. 146, 389-403 (1999).
52. Klemke, R. L. et al. Regulation of cell motility by mitogen-activated protein kinase. J. Cell. Biol. 137, 481-192 (1997).
53. Huang, C., Rajfur, Z., Borchers, C., Schaller, M. D. & Jacobson, K. JNK phosphorylates paxillin and regulates cell migration. Nature 424, 219-223 (2003).
54. Ishibe, S., Joly, D., Zhu, X. & Cantley, L. G. Phosphorylation- dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Mol. Cell 12, 1275-1285 (2003).
55. Li, G. et al. c-Jun is essential for organization of the epidermal leading edge. Dev. Cell 4, 865-877 (2003).
56. Raftopoulou, M. & Hall, A. Cell migration: Rho GTPases lead the way. Dev. Biol. 265, 23-32 (2004).
57. Keely, P. J., Westwick, J. K., Whitehead, I. P, Der, C. J. & Parise, L. V. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 390, 632-636 (1997).
58. Pollard, T. D. & Borisy, G. G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453-465 (2003).
59. Edwards, D. C., Sanders, L. C., Bokoch, G. M. & Gill, G. N. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nature Cell Biol. 1, 253-259 (1999).
60. Etienne-Manneville, S. & Hall, A. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCζ. Cell 106, 489-498 (2001). Shows that integrin signalling at the leading edge regulates, through Cdc42 and PAR6-PKCζ, cell polarity during migration.
61. Watanabe, N., Kato, T., Fujita, A., Ishizaki, T. & Narumiya, S. Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nature Cell Biol. 1, 136-143 (1999).
62. Kimura, K. et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase), Science 273, 245-248 (1996).
63. Sahai, E. & Marshall, C. J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nature Cell Biol. 5, 711-719 (2003). Shows a key role for Rho-ROCK signalling during amoeboid invasion of tumour cells.
64. Itoh, K. et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nature Med. 5, 221-225 (1999).
65. Clark, E. A., Golub, T. R., Under, E. S. & Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535 (2000). Identifies, through global gene-expression analysis, RhoC as an important determinant for melanoma metastasis.
66. Stemlicht, M. D. & Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516 (2001).
67. 3 in melanoma cells promotes the transition from the radial, non-invasive to the vertical, invasive growth phase.
68. 3 integrin promotes the invasion of tumour cells by recruiting active MMP2 to the cell surface.
69. Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M. & Cheresh, D. A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92, 391-400 (1998).
70. Chapman, H. A. & Wei, Y. Protease crosstalk with integrins: the urokinase receptor paradigm. Thromb. Haemost. 86, 124-129 (2001).
71. Blasi, F. & Carmeliet, P. uPAR: a versatile signalling orchestrator. Nature Rev. Mol. Cell Biol. 3, 932-943 (2002).
72. Hauck, C. R., Hsia, D. A., Puente, X. S., Cheresh, D. A. & Schlaepfer, D. D. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J. 21, 6289-6302 (2002).
73. Hsia, D. A. et al. Differentia regulation of cell motility and invasion by FAK. J. Cell Biol. 160, 753-767 (2003).
74. Liu, D., Aguirre-Ghiso, J., Estrada, Y. & Ossowski, L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1, 445-457 (2002). Shows that uPAR enhances joint integrin-RTK signalling during carcinoma growth.
75. Kjoller, L. & Hall, A. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J. Cell Biol. 152, 1145-1157 (2001).
76. Patarroyo, M., Tryggvason, K. & Virtanen, I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin. Cancer Biol. 12, 197-207 (2002).
77. Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K. & Quarante, V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148, 615-624 (2000).
78. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G. & Quaranta, V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228 (1997).
79. Xu, J. et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth S., vivo. J. Cell Biol. 154, 1069-1080 (2001).
80. 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J. 8, 673-680 (1989).
81. 4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation. EMBO J. 16, 2365-2375 (1997).
82. Dajee, M. et al. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421, 639-643 (2003).
83. 4 promotes invasion of tumour cells, and implies that it does so through activation of PI3K.
84. 4 integrin in the control of HGF-dependent invasive growth. Cell 107, 643-654 (2001).
85. 4 integrin in conferring resistance to apoptotic stimuli in breast carcinoma cells.
86. 4 integrin and activates RAC and NFκB mediate anchorage-independent survival of mammary tumors. J. Cell Biol. 163, 1397-1407 (2003).
87. 4 from a pro-adhesive to a pro-migratory receptor, through disruption of hemidesmosomes and activation of SHC and PI3K.
88. 1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp. Cell Res. 236, 76-85 (1997).
89. 1 O3P, integrins via 14-3-3 proteins in keratinocyte migration. Dev. Cell 5, 257-271 (2003).
90. 1, suppresses malignant conversion. Cancer Res. 61, 5248-5254 (2001).
91. Wary, K. K. Mainiero, F., Isakoff, S. J., Marcantonio, E. E. & Giancotti, F. G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell 87, 733-743 (1996).
92. 2 cytoplasmic tail. J. Cell Biol. 147, 401-116 (1999).
93. Ellinger-Ziegelbauer, H., Kelly, K. & Siebenlist, U. Cell cycle arrest and reversion of Ras-induced transformation by a condttionally activated form of mitogen-activated protein kinase kinase kinase 3. Mol. Cell. Biol. 19, 3857-3868 (1999).
94. Chan, B. M., Matsuura, N., Takada, Y., Zetter, B. R. & Hemler, M. E. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 251, 1600-1602 (1991).
95. 1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J. Cell. Biol. 164, 935-941 (2004).
96. Byzova, T. V. et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell 6, 851-860 (2000).
97. Klein, S., Biktalvi, A., Birkenmeier, T. M. Giancotti, F. G. & Rifkin, D. B. Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J. Biol. Chem. 271, 22583-22590 (1996).
98. Rehn, M. et al. Interaction of endostatin wfth integrins implicated in angiogenesis. Proc. Natl Acad. Sci. USA 98, 1024-1029 (2001).
99. 1 integrin. Cancer Cell 3, 589-601 (2003).
100. Sheppard, D. Endothelial integrins and angiogenesis: not so simple anymore. J. Clin. Invest. 110, 913-914 (2002).
101. Frisch, S. M. & Ruoslahti, E. Integrins and anoikis. Curr. Opin. Cell Biol. 9, 701-706 (1997).
102. Frisch, S. M., Vuori, K., Ruoslahti, E. & Chan-Hui, P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793-799 (1996).
103. Khwaja, A., Rodriguez-vïaana, P., Wennstrom, S., Warne, P. H. & Downward, J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16, 2783-2793(1997). References 102 and 103 provide evidence that FAK promotes cell survival through signalling from PI3K to AKT/PKB.
104. 1 integrin supports survival of cells on fibronectin and upregulates Bcl-2 expression. Proc. Natl Acad. Sci. USA 92, 6161-6165 (1995).
105. Reginato, M. J. et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nature Cell Biol. 5, 733-740 (2003).
106. Butt, A. J., Firth, S. M. & Baxter, R. C. The IGF axis and programmed cell death. Immunol. Cell Biol. 77, 255-262 (1999).
107. Lotem, J. & Sachs, L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 10, 925-931 (1996).
108. Tamura, M. et al. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 274, 20693-20703 (1999).
109. Fridman, J. S. & Lowe, S. W. Control of apoptosis by p53. Oncogene 22, 9030-9040 (2003).
110. Ilic, D. et al. Extracellular matrix survival signas transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143, 547-560 (1998).
111. Frisch, S. M. Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis. Curr. Biol. 9, 1047-1049 (1999).
112. Rytomaa, M., Martins, L. M. & Downward, J. Involvement of FADD and caspase-8 signaling in detachment-induced apoptosis. Curr. Biol. 9, 1043-1046 (1999).
113. Aoudjit, F. & Vuori, K. Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J. Cell Biol. 152, 633-643 (2001).
114. Pitti, R. M. et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396, 699-703 (1998).
115. Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M. & Cheresh, D. A. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J. Cell Biol. 155, 459-470 (2001).
116. INK4a contributes to resistance to anoikis in tumour cells.
117. 4 integrin. J. Biol. Chem. 274, 20733-20737 (1999).
118. Camerer, E. et al. Platelets, protease-aotivated receptors, and fibrinogen in hematogenous metastasis. Blood 104, 397-101 (2004).
119. 4 integrin ligation to mCLCA1 mediates early metastatic growth. J. Biol. Chem. 277, 34391-34400 (2002).
120. 3 and cell adhesion molecule L1 in transendothelia migration of melanoma cells. Mol. Biol. Cell 12, 2699-2710 (2001).
121. Parsons, J. T. & Parsons, S. J. Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr. Opin. Cell Biol. 9, 187-192 (1997).
122. Schlaepfer, D. D. & Hunter, T. Integrin signalling and tyrosine phosphorylation: just the FAKs? Trends Cell Biol. 8, 151-157 (1998).
123. Cary, L. A., Man, D. C. & Guan, J. L. Integrin-mediated signal transduction pathways. Histol. Histopathol. 14, 1001-1009 (1999).
124. Wary, K. K., Mariotti, A., Zurzolo, C. & Giancotti, F. G. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell 94, 625-634 (1998).
125. Arias-Salgado, E. G. et al. Src kinase activation by direct interaction with the integrin β cytoplasrnic domain. Proc. Natl Acad. Sci. USA 100, 13298-13302 (2003).
126. 4 signaling in lipid rafts. J. Cell Biol. 162, 1189-1196 (2003).
127. 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes. EMBOJ. 14, 4470-4481 (1995).
128. 4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol. Cell Biol. 21, 5082-5093 (2001).
129. 4 integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J. Biol. Chem. 275, 10604-10610 (2000).
130. 3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGR EMBO J. 16, 5600-5607 (1997).
131. Dai, C. et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliornas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15, 1913-1925 (2001).